(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
99%
blur_circular Chemical Specifications
description Product Description
This compound is primarily used in the treatment of gastrointestinal disorders, particularly those related to excessive stomach acid production. It functions as a proton pump inhibitor (PPI), effectively reducing the amount of acid produced in the stomach. This makes it highly effective in managing conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Additionally, it is often prescribed to prevent and treat ulcers caused by prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs). The compound is also utilized in combination therapies for the eradication of Helicobacter pylori, a bacterium linked to gastric ulcers and chronic gastritis. Its mechanism of action involves the inhibition of the H+/K+ ATPase enzyme in the gastric parietal cells, leading to a significant reduction in gastric acid secretion. This provides relief from symptoms like heartburn, acid regurgitation, and stomach pain, while also promoting the healing of damaged esophageal and gastric tissues.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| APPEARANCE | White to yellow to gray powder or crystals |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
shopping_cart Available Sizes & Pricing
Cart
No products